跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Vexprazole 40 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Vexprazole 40
Approved
STANDARD
Vexprazole 40
Akums Drugs & Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
a0c6111c616e43a8
Company
Akums Drugs & Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
a0c6111c616e43a8
Drug Approval Philippines Name
Vexprazole 40
Product Name
Vexprazole 40
Registration Number
DRP-7026
Brand Name
Vexprazole 40
Generic Name
Pantoprazole (as sodium sesquihydrate)
Dosage Form
Delayed-Released Tablet
Dosage Strength
40mg
Manufacturer
Akums Drugs & Pharmaceuticals Ltd.
Trader
Vexxa Lifeciences Pvt. Ltd.
Importer
VE Pharma, Inc.
Distributor
VE Pharma, Inc.
Company Detail Path
/organization/akums-drugs-and-pharmaceuticals-ltd
Issuance Date
29 December 2023
Expiry Date
12 November 2029
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
a0c6111c616e43a8
Type
Standard
Back to Philippines FDA Approvals